Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

[3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain

Rebecca A. Wright, M. Brian Arnold, William J. Wheeler, Paul L. Ornstein and Darryle D. Schoepp
Journal of Pharmacology and Experimental Therapeutics August 2001, 298 (2) 453-460;
Rebecca A. Wright
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Brian Arnold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William J. Wheeler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Ornstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darryle D. Schoepp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

[3H]LY341495 is a highly potent and selective antagonist for group II metabotropic glutamate (mGlu) receptors (mGlu2 and mGlu3), which has been used to label these receptors in cells expressing recombinant receptor subtypes. In this study, we characterized the kinetics, pharmacology, and distribution of [3H]LY341495 binding to mGlu receptors in rat brain tissue. Equilibrium experiments in the rat forebrain demonstrated binding to a single site that was saturable, reversible, and of high affinity (Bmax, 3.9 ± 0.65 pmol/mg of protein,Kd, 0.84 ± 0.11 nM). The relative order of potencies for displacement of [3H]LY341495 by mGlu receptor ligands was LY341495 ≫ l-glutamic acid > LY354740 > (2S,1′S,2′S)-2-(carboxycyclopropyl)glycine > 4-(2R,4R)-aminopyrrolidine-2,4-dicarboxylate > (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid > (R,S)-α-methyl-4-phosphonophenylglycine > (R,S)3,5-dihydroxyphenylglycine > l-(+)-2-amino-4-phosphonobutyric acid. [3H]LY341495 was not displaced by the selective ionotropic glutamate receptor agonistsN-methyl-d-aspartic acid, (R,S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, or kainate at concentrations up to 1 mM. Comparison of [3H]LY341495 binding in rat brain with recombinant mGlu receptor subtypes demonstrated a very high correlation with mGlu3 receptor binding (r2 = 0.957), a significant, but lower, correlation with mGlu2 receptor binding (r2 = 0.869), but no significant correlation to mGlu8 receptor binding (r2 = 0.284). Regional studies using autoradiography showed a similar distribution of [3H]LY341495 binding to that for group II mGlu receptors previously reported by others using immunocytochemical techniques. These studies indicate that [3H]LY341495 selectively labels group II (mGlu2/3) receptors, but under the conditions used, [3H]LY341495 may bind predominately to mGlu3 receptor populations in the rat forebrain.

Footnotes

  • Abbreviations:
    mGlu
    metabotropic glutamate
    l-CCG-I
    (2S,1′S,2′S)-2-(carboxycyclopropyl)glycine
    1S,3R-ACPD
    (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid
    l-AP3
    l-(+)-2-amino-4-phosphonopropionic acid
    l-AP4
    l-(+)-2-amino-4-phosphonobutyric acid
    DCG-IV
    n-(2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine
    DHPG
    (RS)-α-methyl-4-phosphonophenylglycine
    MPPG
    (R,S)3,5-dihydroxyphenylglycine
    2R,4R-APDC
    4-(2R,4R)-aminopyrrolidine-2,4-dicarboxylate
    1S,3S-ACPD
    (1S,3S-)-1-aminocyclopentane-1,3-dicarboxylic acid
    AMPA
    (R,S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
    NMDA
    N-methyl-d-aspartic acid
    t-PDC
    l-trans-pyrrolidine-2,4-dicarboxylic acid
    MPDC
    l-anti-endo-3,4-methanopyrrolidinedicarboxylic acid
    MCPG
    (S)-α-methyl-4-carboxyphenyl glycine
    NAAG
    N-acetyl-l-aspartyl-l-glutamic acid
    SITS
    4-acetamido-4′-isothiocyanostilbene-2,2′-disulfonic acid
    (RS)PPG
    (R,S)-4-phosphonophenylglycine
    • Received January 22, 2001.
    • Accepted May 3, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 298 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 298, Issue 2
1 Aug 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
[3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

[3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain

Rebecca A. Wright, M. Brian Arnold, William J. Wheeler, Paul L. Ornstein and Darryle D. Schoepp
Journal of Pharmacology and Experimental Therapeutics August 1, 2001, 298 (2) 453-460;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNEUROPHARMACOLOGY

[3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain

Rebecca A. Wright, M. Brian Arnold, William J. Wheeler, Paul L. Ornstein and Darryle D. Schoepp
Journal of Pharmacology and Experimental Therapeutics August 1, 2001, 298 (2) 453-460;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Iclepertin (BI 425809) in schizophrenia-related models
  • D1 agonist vs. methylphenidate on PFC working memory
  • Obesity Thwarts Preconditioning in TBI
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics